Cargando…
Amyloid precursor protein mutation E682K at the alternative β-secretase cleavage β′-site increases Aβ generation†
BACE1 cleaves the amyloid precursor protein (APP) at the β-cleavage site (Met(671)–Asp(672)) to initiate the generation of amyloid peptide Aβ. BACE1 is also known to cleave APP at a much less well-characterized β′-cleavage site (Tyr(681)–Glu(682)). We describe here the identification of a novel APP...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377078/ https://www.ncbi.nlm.nih.gov/pubmed/21500352 http://dx.doi.org/10.1002/emmm.201100138 |
_version_ | 1782235915967528960 |
---|---|
author | Zhou, Lujia Brouwers, Nathalie Benilova, Iryna Vandersteen, Annelies Mercken, Marc Van Laere, Koen Van Damme, Philip Demedts, David Van Leuven, Fred Sleegers, Kristel Broersen, Kerensa Van Broeckhoven, Christine Vandenberghe, Rik De Strooper, Bart |
author_facet | Zhou, Lujia Brouwers, Nathalie Benilova, Iryna Vandersteen, Annelies Mercken, Marc Van Laere, Koen Van Damme, Philip Demedts, David Van Leuven, Fred Sleegers, Kristel Broersen, Kerensa Van Broeckhoven, Christine Vandenberghe, Rik De Strooper, Bart |
author_sort | Zhou, Lujia |
collection | PubMed |
description | BACE1 cleaves the amyloid precursor protein (APP) at the β-cleavage site (Met(671)–Asp(672)) to initiate the generation of amyloid peptide Aβ. BACE1 is also known to cleave APP at a much less well-characterized β′-cleavage site (Tyr(681)–Glu(682)). We describe here the identification of a novel APP mutation E682K located at this β′-site in an early onset Alzheimer's disease (AD) case. Functional analysis revealed that this E682K mutation blocked the β′-site and shifted cleavage of APP to the β-site, causing increased Aβ production. This work demonstrates the functional importance of APP processing at the β′-site and shows how disruption of the balance between β- and β′-site cleavage may enhance the amyloidogenic processing and consequentially risk for AD. Increasing exon- and exome-based sequencing efforts will identify many more putative pathogenic mutations without conclusive segregation-based evidence in a single family. Our study shows how functional analysis of such mutations allows to determine the potential pathogenic nature of these mutations. We propose to classify the E682K mutation as probable pathogenic awaiting further independent confirmation of its association with AD in other patients. |
format | Online Article Text |
id | pubmed-3377078 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | WILEY-VCH Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-33770782012-09-17 Amyloid precursor protein mutation E682K at the alternative β-secretase cleavage β′-site increases Aβ generation† Zhou, Lujia Brouwers, Nathalie Benilova, Iryna Vandersteen, Annelies Mercken, Marc Van Laere, Koen Van Damme, Philip Demedts, David Van Leuven, Fred Sleegers, Kristel Broersen, Kerensa Van Broeckhoven, Christine Vandenberghe, Rik De Strooper, Bart EMBO Mol Med Research Articles BACE1 cleaves the amyloid precursor protein (APP) at the β-cleavage site (Met(671)–Asp(672)) to initiate the generation of amyloid peptide Aβ. BACE1 is also known to cleave APP at a much less well-characterized β′-cleavage site (Tyr(681)–Glu(682)). We describe here the identification of a novel APP mutation E682K located at this β′-site in an early onset Alzheimer's disease (AD) case. Functional analysis revealed that this E682K mutation blocked the β′-site and shifted cleavage of APP to the β-site, causing increased Aβ production. This work demonstrates the functional importance of APP processing at the β′-site and shows how disruption of the balance between β- and β′-site cleavage may enhance the amyloidogenic processing and consequentially risk for AD. Increasing exon- and exome-based sequencing efforts will identify many more putative pathogenic mutations without conclusive segregation-based evidence in a single family. Our study shows how functional analysis of such mutations allows to determine the potential pathogenic nature of these mutations. We propose to classify the E682K mutation as probable pathogenic awaiting further independent confirmation of its association with AD in other patients. WILEY-VCH Verlag 2011-05 /pmc/articles/PMC3377078/ /pubmed/21500352 http://dx.doi.org/10.1002/emmm.201100138 Text en Copyright © 2011 EMBO Molecular Medicine |
spellingShingle | Research Articles Zhou, Lujia Brouwers, Nathalie Benilova, Iryna Vandersteen, Annelies Mercken, Marc Van Laere, Koen Van Damme, Philip Demedts, David Van Leuven, Fred Sleegers, Kristel Broersen, Kerensa Van Broeckhoven, Christine Vandenberghe, Rik De Strooper, Bart Amyloid precursor protein mutation E682K at the alternative β-secretase cleavage β′-site increases Aβ generation† |
title | Amyloid precursor protein mutation E682K at the alternative β-secretase cleavage β′-site increases Aβ generation† |
title_full | Amyloid precursor protein mutation E682K at the alternative β-secretase cleavage β′-site increases Aβ generation† |
title_fullStr | Amyloid precursor protein mutation E682K at the alternative β-secretase cleavage β′-site increases Aβ generation† |
title_full_unstemmed | Amyloid precursor protein mutation E682K at the alternative β-secretase cleavage β′-site increases Aβ generation† |
title_short | Amyloid precursor protein mutation E682K at the alternative β-secretase cleavage β′-site increases Aβ generation† |
title_sort | amyloid precursor protein mutation e682k at the alternative β-secretase cleavage β′-site increases aβ generation† |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377078/ https://www.ncbi.nlm.nih.gov/pubmed/21500352 http://dx.doi.org/10.1002/emmm.201100138 |
work_keys_str_mv | AT zhoulujia amyloidprecursorproteinmutatione682katthealternativebsecretasecleavagebsiteincreasesabgeneration AT brouwersnathalie amyloidprecursorproteinmutatione682katthealternativebsecretasecleavagebsiteincreasesabgeneration AT benilovairyna amyloidprecursorproteinmutatione682katthealternativebsecretasecleavagebsiteincreasesabgeneration AT vandersteenannelies amyloidprecursorproteinmutatione682katthealternativebsecretasecleavagebsiteincreasesabgeneration AT merckenmarc amyloidprecursorproteinmutatione682katthealternativebsecretasecleavagebsiteincreasesabgeneration AT vanlaerekoen amyloidprecursorproteinmutatione682katthealternativebsecretasecleavagebsiteincreasesabgeneration AT vandammephilip amyloidprecursorproteinmutatione682katthealternativebsecretasecleavagebsiteincreasesabgeneration AT demedtsdavid amyloidprecursorproteinmutatione682katthealternativebsecretasecleavagebsiteincreasesabgeneration AT vanleuvenfred amyloidprecursorproteinmutatione682katthealternativebsecretasecleavagebsiteincreasesabgeneration AT sleegerskristel amyloidprecursorproteinmutatione682katthealternativebsecretasecleavagebsiteincreasesabgeneration AT broersenkerensa amyloidprecursorproteinmutatione682katthealternativebsecretasecleavagebsiteincreasesabgeneration AT vanbroeckhovenchristine amyloidprecursorproteinmutatione682katthealternativebsecretasecleavagebsiteincreasesabgeneration AT vandenbergherik amyloidprecursorproteinmutatione682katthealternativebsecretasecleavagebsiteincreasesabgeneration AT destrooperbart amyloidprecursorproteinmutatione682katthealternativebsecretasecleavagebsiteincreasesabgeneration |